Authors: Gabrielle Gimenes Lima and Anderson Rossatto (FEBRAF, Brazil).
Cardiovascular diseases (CVDs) are one of the great challenges of global health. It is estimated
that CVDs are responsible for more than 17 million deaths / year in the world, which
corresponds to more than 30% of the total deaths on the planet (PAHO, 2017). In Brazil,
circulatory system disorders, in addition to being the main cause of death, also stand out
among the biggest reasons for hospitalization, which generates high costs for the Brazilian
The increase in life expectancy and the incidence of cardiovascular risk factors, such as diabetes
and uncontrolled arterial hypertension, represent the main reasons for the increasing increase
in CVDs in Brazil in recent years, since, on the one hand, scientific advances in combating
diseases and the improvement of health-related care have contributed to increasing the
longevity of the world population, on the other hand, increasing age, by itself, expands the risk
of the development of chronic diseases, especially cardiovascular diseases, whose incidence
doubles, in on average, for every decade of life in adults.
The scarcity of cardiologists in primary and hospital care units associated with the high demand
for tasks, particularly in public health services, requires the collaboration of non-medical health
professionals as an efficient and cost-effective way to improve the quality of care for patients.
The pharmacist, being able to identify and solve problems related to the use of medications,
can make a significant contribution to the multidisciplinary health team regarding the
monitoring of pharmacotherapy of inpatients and outpatients, helping to optimize
pharmacological therapy, identifying effects adverse effects and drug interactions, patient
education, development of autonomy and responsibility in self-care with health and prior
identification of prescription errors and use of medications.5
BRANT LCC, et al. Variações e diferenciais da mortalidade por doença cardiovascular no
Brasil e em seus estados, em 1990 e 2015: estimativas do estudo carga global de
doença. Revista Brasileira de Epidemiologia, 2017; 20(1): 116-128.
PEREIRA JC, et al. O perfil de saúde cardiovascular dos idosos brasileiros precisa
melhorar: estudo de base populacional. Arquivos Brasileiros de Cardiologia, 2008;
DUNN SP, et al. The role of the clinical pharmacist in the care of patients with
cardiovascular disease. Journal of the American College of Cardiology, 2015; 66(19):
KUO GR, et al. Drug errors and related interventions reported by United States clinical
pharmacists: The American College of Clinical Pharmacy Practice-Based Research
Network Medication Error Detection, Amelioration and Prevention Study.
Pharmacotherapy, 2013: 33 (3): 253-265.